Thomas O. Daniel, M.D. has been appointed president of Celgene Research, responsible for leading the discovery, preclinical and early stage clinical programs for the company worldwide. Dr. Daniel has more than 20 years of medical and pharmaceutical research experience. He most recently served as the chief scientific officer at Ambryx, Inc., a biotechnology company focused on discovering and developing protein-based therapeutics. Prior to that, Dr. Daniel was vice president of research at Amgen, ...